| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | China | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Australia | 1 | |
| #6 | Finland | 1 | |
| #7 | Hungary | 1 | |
| #8 | Slovenia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pesonen Sari | 14 |
| #2 | Ranki Tuuli | 13 |
| #3 | Kuryk Lukasz | 12 |
| #4 | Haavisto Elina | 12 |
| #5 | Vuolanto Antti | 12 |
| #6 | Jäderberg Magnus | 6 |
| #7 | Cerullo Vincenzo | 5 |
| #8 | Vassilev Lotta | 5 |
| #9 | Hemminki Akseli | 5 |
| #10 | Kanerva Anna | 4 |
| Publication | Filing date | Title |
|---|---|---|
| EP3783032A1 | Combining adenovirus and checkpoint inhibitors for treating cancer | |
| US2016208287A1 | Adenoviral vectors and methods and uses related thereto | |
| FI20165026A | Combining adenovirus and chemotherapeutic agents for treating cancer | |
| US2015232811A1 | Recombinant serotype 5 (Ad5) adenoviral vectors | |
| EP2379586A1 | Oncolytic adenoviral vectors and methods and uses related thereto |